4-amino-1,8-naphthalimide has been researched along with Arthritis, Rheumatoid in 1 studies
4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García, S | 1 |
| Bodaño, A | 1 |
| Pablos, JL | 1 |
| Gómez-Reino, JJ | 1 |
| Conde, C | 1 |
1 other study available for 4-amino-1,8-naphthalimide and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
Topics: 1-Naphthylamine; Apoptosis; Arthritis, Rheumatoid; Blotting, Western; Cell Proliferation; Cells, Cul | 2008 |